Author Archives: Aisha I Abdullah PhD

Galyan Bio Plans to Start Clinical Testing of Oral Therapy in 2022

Galyan Bio plans to initiate a clinical trial of a small molecules candidate that aims to slow the progression of Huntington’s disease next year, working in with Bicoll GmbH. Galyan Bio is developing and optimizing small molecules as oral treatments of Huntington’s and other neurodegenerative disorders, which work by targeting disease-causing mutant…